BRAXF / Braxia Scientific says it continues psychedelic-based clinical research trials to support future drug development

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has reported a significant increase in treatment volumes across its clinics, which rose by 26.2% in fi more_horizontal

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said it has closed the first tranche of its previously announced non-brokered offering resulting in the more_horizontal

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has announced an offering of up to 27,272,727 units of the company at a price of $0.055 each for aggrega more_horizontal

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has announced an increase in revenues for its second quarter and the first half ended September 30, 202 more_horizontal

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) (Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF), Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF)) has annou more_horizontal

Braxia Scientific Corp has reported a near 50% increase in revenue in its fiscal year to end-March 2022 as it looks to "significantly" scale its offe more_horizontal

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) has announced the appointments of Jason Wolkove as the company's new chief information officer (CIO) as more_horizontal

Braxia Scientific Corp has announced the opening of its newest Braxia Health clinic in the Kitchener-Waterloo area in Ontario, its fifth locatio more_horizontal